TITLE

GLYCEMIC TARGETS IN DIABETES CARE: EMERGING CLARITY AFTER ACCORD

AUTHOR(S)
BUSE, JOHN B.
PUB. DATE
January 2015
SOURCE
Transactions of the American Clinical & Climatological Associati;2015, Vol. 126, p62
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Through the 1990s convincing evidence emerged from studies involving relatively recent onset diabetes that glycemic control achieving glycated hemoglobin A1c levels of approximately 7% was associated with improved microvascular outcomes. Based on advocacy groups' statements encouraging lower targets and recognition of cardiovascular disease as the leading cause of death in diabetes, the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study was funded in 1999 to explore more intensive targets and techniques in the treatment of type 2 diabetes. Most surprisingly, intensive management targeting normal levels of glycemia was associated with increased mortality and the ACCORD trial was terminated early in 2008. Post hoc analyses have allowed the emergence of some clarity around the role of glycemic management and targets in diabetes care and are the subject of this review.
ACCESSION #
109286966

 

Related Articles

  • Antioxidant Potential and Inhibition of Key Enzymes Linked to Alzheimer's Diseases and Diabetes Mellitus by Monoterpene-Rich Essential Oil from Sideritis galatica Bornm. Endemic to Turkey. Zengin, Gökhan; Sarıkürkçü, Cengiz; Aktümsek, Abdurrahman; Ceylan, Ramazan // Records of Natural Products;2016, Vol. 10 Issue 2, p195 

    The present study was designated to (1) characterize the essential oil from S. galatica (SGEOs) and (2) evaluate its antioxidant and enzyme inhibitory activities. Antioxidant capacity was tested different methods including free radical scavenging (DPPH, ABTS and NO), reducing power (FRAP and...

  • Baicalein Protects against Type 2 Diabetes via Promoting Islet ß-Cell Function in Obese Diabetic Mice. Yu Fu; Jing Luo; Zhenquan Jia; Wei Zhen; Kequan Zhou; Gilbert, Elizabeth; Dongmin Liu // International Journal of Endocrinology;2014, p1 

    In both type 1 (T1D) and type 2 diabetes (T2D), the deterioration of glycemic control over time is primarily caused by an inadequate mass and progressive dysfunction of ß-cell, leading to the impaired insulin secretion. Here, we show that dietary supplementation of baicalein, a flavone...

  • Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data.  // Cardiovascular Diabetology;2012, Vol. 11 Issue 1, p6 

    The article presents a research which examines the efficacy of cardiovascular (CV) safety of the selective dipeptidyl peptidase-4 (DPP-4) inhibitor saxagliptin for the treatment of type 2 diabetes mellitus (T2DM). It is reported that, the researchers carried out a retrospective meta-analysis to...

  • ACCORD's methods of glycaemic control "imprudent.".  // Reactions Weekly;7/10/2010, Issue 1309, p4 

    The article analyzes the ACCORD randomised trial involving type 2 diabetes patients. The trial has concluded that the intensive hyperglycaemia management is unwise for patients with longstanding type 2 diabetes mellitus in line with the risks for total and cardiovascular-related mortality....

  • Prevalence of Diabetes in Urban Haryana. Arora, Varun; Malik, Jagbir Singh; Khanna, Pardeep; Goyal, Noopur; kumar, Naresh; singh, Manjeet // Australasian Medical Journal;Aug2010, Vol. 3 Issue 8, p488 

    Background Diabetes will pose a severe burden on the already fragile and under resourced health care system in India. As there is limited data available regarding prevalence of diabetes in northern India, the present study was undertaken to estimate the prevalence of diabetes mellitus and to...

  • New type 2 diabetes treatment algorithm emphasizes comprehensive approach.  // Pharmacy Today;Jul2013, Vol. 19 Issue 7, p17 

    The article reports on the type 2 diabetes treatment algorithm launched by the American Association of Clinical Endocrinologists (AACE). It mentions that the algorithm covers drug treatment for prediabetes, obesity and cardiovascular disease. It also notes a suggestion of stratifying diabetes...

  • Association of LRP5 gene polymorphism with type 2 diabetes mellitus and osteoporosis in postmenopausal women. Miao Xuan; Yonglan Wang; Wenxing Wang; Jun Yang; Ying Li; Xiuzhen Zhang // International Journal of Clinical & Experimental Medicine;2014, Vol. 7 Issue 1, p247 

    This study was to explore the association of low-density lipoprotein receptor related protein 5 (LRP5) gene polymorphism with bone mineral density (BMD), bone turnover markers and glycometabolism in postmenopausal women with type 2 diabetes mellitus (T2DM) and/or osteoporosis (OP) in Shanghai....

  • Urinary patterns analysis of type 2 diabetes mellitus patients by nuclear magnetic resonance spectroscopy method (1H-NMR). Stefan, L. I.; Nicolescu, A.; Sandu, M.; Popa, G. S.; Moţa, M.; Deleanu, C. // Biochemia Medica;2014 Supplement, Vol. 24, pS61 

    Background: Proton nuclear magnetic resonance spectroscopy method (1H-NMR) was applied to investigate the urinary patterns of type 2 diabetes mellitus (T2DM) patients to identify possible disturbances that may accompany T2DM. We investigate the potential relationship between diabetic retinopathy...

  • Diabetes Mellitus. Migdalis, Ilias; Leslie, David; Papanas, Nikolaos; Valensi, Paul; Vlassara, Helen // International Journal of Endocrinology;2014, p1 

    No abstract available.

Share

Other Topics